{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:26:58Z","timestamp":1794983218158,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ijpharm.2018.01.005","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T20:36:02Z","timestamp":1516134962000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Quantitative estimation of phenytoin sodium disproportionation in the formulations using vibration spectroscopies and multivariate methodologies"],"prefix":"10.1016","volume":"539","author":[{"given":"Sathish","family":"Dharani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyaur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sogra F.","family":"Barakh Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamideh","family":"Afrooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.01.005_b0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/wics.51","article-title":"Partial least squares regression and projection on latent structure regression (PLS Regression)","volume":"2","author":"Abdi","year":"2010","journal-title":"Wiley Interdiscip. Rev. Comput. Stat."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0378-5173(78)90017-0","article-title":"Some factors influencing the in vitro release of phenytoin from formulations","volume":"1","author":"Bastami","year":"1978","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0015","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00216-008-2426-9","article-title":"Development of a univariate calibration model for pharmaceutical analysis based on NIR spectra","volume":"392","author":"Blanco","year":"2008","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0020","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.3390\/s110908309","article-title":"Micro-Raman spectroscopy and univariate analysis for monitoring disease follow-up","volume":"11","author":"Camerlingo","year":"2011","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.ijpharm.2018.01.005_b0025","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jpba.2006.12.020","article-title":"Development and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products","volume":"43","author":"Ciavarella","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0030","unstructured":"Dilantin 30\u00ae and Dilantin 125\u00ae-Phenytoin suspension. Accessed on July 23, 2017. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=008762."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0035","unstructured":"Dilantin\u00ae-Phenytoin sodium injection. Accessed on July 23, 2017. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=010151."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0040","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/j.1875-9114.1998.tb03128.x","article-title":"Bioavailability of phenytoin acid and phenytoin sodium with enteral feedings","volume":"18","author":"Doak","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijpharm.2018.01.005_b0045","unstructured":"Drugs@FDA: FDA Approved drug products: Phenytoin. Accessed on July 23, 2017. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=BasicSearch.process."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.53879\/id.53.11.10683","article-title":"Assessment of different partial least squares variants for determination of binary-drug system exhibiting intense spectral overlap","volume":"53","author":"Fasfous","year":"2016","journal-title":"Indian Drugs"},{"key":"10.1016\/j.ijpharm.2018.01.005_b0055","unstructured":"FDA guidance for industry: Development and Submission of Near Infrared Analytical Procedures Guidance for Industry 2015. Accessed on June 27, 2017. https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM440247.pdf."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cpt1976192135","article-title":"Phenytoin: pharmacokinetics and bioavailability","volume":"19","author":"Gugler","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0065","unstructured":"Huang, J., Romero-Torres, S., Moshgbar, M., 2010. Practical considerations in data pre-treatment for NIR and Raman spectroscopy. Am Pharm Rev. Access on June 29, 2017. http:\/\/www.americanpharmaceuticalreview.com\/Featured-Articles\/116330-Practical-Considerations-in-Data-Pre-treatment-for-NIR-and-Raman-Spectroscopy\/."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0070","unstructured":"Istvan, T., Modra, D., 2013. Obtaining the phenytoin and the influence of different reaction parameters. Annals West University of Timisoara, Series of Chemistry. 22, 67-76. Accessed on July 14. http:\/\/www.elearningchemistry.ro\/awut\/userfiles\/magazine1_acc\/67_76_IsvanT_ModraD.pdf."},{"issue":"S1","key":"10.1016\/j.ijpharm.2018.01.005_b0075","first-page":"S47","article-title":"Application of green chemistry principle in synthesis of phenytoin and its biogical evaluation as anticonvulsant agents","volume":"8","author":"Kadam","year":"2011","journal-title":"Eur. J. Chem."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0080","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/j.1875-9114.1998.tb03128.x","article-title":"Bioavailability of phenytoin acid and phenytoin sodium with enteral feedings","volume":"18","author":"Karen","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijpharm.2018.01.005_b0085","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3109\/03639045.2015.1058817","article-title":"Application of NIR chemometric methods for quantification of the crystalline fraction of warfarin sodium in drug product","volume":"42","author":"Maxwell","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0090","unstructured":"Phenytoin and phenytoin sodium. Reports on carcinogens, U.S. Department of Health and Human Services, 14th edition, 2016. Access on July 24, 2017. https:\/\/ntp.niehs.nih.gov\/ntp\/roc\/content\/profiles\/phenytoin.pdf."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0095","first-page":"268","article-title":"Monitoring of drugs with a narrow therapeutic range in ambulatory care","volume":"12","author":"Raebel","year":"2006","journal-title":"Am. J. Manage. Care."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2015.08.065","article-title":"Understanding effect of formulation and manufacturing variables on the critical quality attributes of warfarin sodium product","volume":"495","author":"Rahman","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0105","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/jps.24524","article-title":"Chemometric model development and comparison of Raman and (13)C solid-state nuclear magnetic resonance-chemometric methods for quantification of crystalline\/amorphous warfarin sodium fraction in the formulations","volume":"104","author":"Rahman","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0110","doi-asserted-by":"crossref","unstructured":"Rinnan, A., N\u00f8rgaard, L., Berg, F.V.D., Thygesen, J., Bro, R., Engelsen, S.B., 2009. Data pre-processing in Infrared spectroscopy for food quality analysis and control Edited by Sun DW, Elsevier, 29\u201350.","DOI":"10.1016\/B978-0-12-374136-3.00002-X"},{"key":"10.1016\/j.ijpharm.2018.01.005_b0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0378-5173(85)90209-1","article-title":"The effects of aging on the dissolution of phenytoin sodium capsule formulations","volume":"26","author":"Rubino","year":"1985","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0120","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/jps.2600660724","article-title":"Solubility and ionization characteristics of phenytoin","volume":"66","author":"Schwartz","year":"1977","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0125","first-page":"64","article-title":"Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study","volume":"81","author":"Suthisisang","year":"1998","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0130","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1021\/acs.molpharmaceut.6b00745","article-title":"Salt disproportionation in the solid state: role of solubility and counterion volatility","volume":"12","author":"Thakral","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0135","first-page":"371","article-title":"Application of micro-Raman and FT \u2013 IR spectroscopy in forensic analysis of questioned documents","volume":"25","author":"Udri\u015ftioiu","year":"2012","journal-title":"GU J. Sci."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jbm.a.32249","article-title":"Characterization of interfacial chemistry of adhesive\/dentin bond using FTIR chemical imaging with univariate and multivariate data processing","volume":"91","author":"Wang","year":"2009","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1255\/jnirs.786","article-title":"Incorporating chemical band-assignment in near infrared spectroscopy regression models","volume":"16","author":"Westad","year":"2008","journal-title":"J. Near Infrared Spectrosc."},{"key":"10.1016\/j.ijpharm.2018.01.005_b0150","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1021\/acs.molpharmaceut.5b00202","article-title":"Dissolution and solubility enhancement of the highly lipophilic drug phenytoin via interaction with poly(N-isopropylacrylamide-co-vinylpyrrolidone) excipients","volume":"12","author":"Widanapathirana","year":"2015","journal-title":"Mol. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731830005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731830005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:34:40Z","timestamp":1759916080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851731830005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S037851731830005X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.01.005","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative estimation of phenytoin sodium disproportionation in the formulations using vibration spectroscopies and multivariate methodologies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}